Catalyst Wire Dossier Catalyst Wire Dossier

Butantan-Dengue vaccine (live attenuated tetravalent)

dengue vaccine, live attenuated, tetravalent · Instituto Butantan
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Butantan-Dengue vaccine (live attenuated tetravalent), covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases [Phase 4]

See pricing